These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 216447)

  • 1. The effects of opiate receptor agonists and antagonists on the stress-induced secretion of corticosterone in mice.
    Gibson A; Ginsburg M; Hall M; Hart SL
    Br J Pharmacol; 1979 Jan; 65(1):139-46. PubMed ID: 216447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the effects of mu- and delta-opioid receptor antagonists upon plasma corticosterone levels in stressed mice.
    Kitchen I; Rowan KM
    Eur J Pharmacol; 1984 May; 101(1-2):153-6. PubMed ID: 6086360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTH and corticosterone response to naloxone and morphine in normal, hypophysectomized and dexamethasone-treated rats.
    Jezová D; Vigas M; Jurcovicová J
    Life Sci; 1982 Jul; 31(4):307-14. PubMed ID: 6292645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term enhancement of morphine hypalgesia as a result of periodic blockade of opiate receptors using naloxone].
    Kiiatkin EA; Zhukov VN
    Biull Eksp Biol Med; 1987 Dec; 104(12):692-5. PubMed ID: 2825840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of naloxone-induced analgesia by pretreatment with morphine.
    Cappell H; Poulos CX; Lê AD
    Pharmacol Biochem Behav; 1989 Oct; 34(2):425-7. PubMed ID: 2560204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum prolactin response to ether stress in diabetic rats: opiate system contribution.
    Yogev L; Yavetz H; Gottreich A; Oppenheim D; Homonnai ZT; Paz G
    Proc Soc Exp Biol Med; 1994 Mar; 205(3):248-52. PubMed ID: 8171046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.
    van Dorp EL; Kest B; Kowalczyk WJ; Morariu AM; Waxman AR; Arout CA; Dahan A; Sarton EY
    Anesthesiology; 2009 Jun; 110(6):1356-63. PubMed ID: 19461298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental responses to opioids reveals a lack of effect on stress-induced corticosterone levels in neonatal rats.
    Bailey CC; Kitchen I
    Br J Pharmacol; 1987 May; 91(1):119-25. PubMed ID: 3594070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of morphine in increasing plasma cyclic GMP level in male mice.
    Muraki T; Ishii K; Kato R
    J Pharmacol Exp Ther; 1983 Feb; 224(2):431-5. PubMed ID: 6296363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intracerebroventricular administration of methionine-enkephalin on the stress-induced secretion of corticosterone in mice.
    Gibson A; Ginsburg M; Hall M; Hart SL
    Br J Pharmacol; 1979 Jun; 66(2):164-6. PubMed ID: 465866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-tolerance and cross-sensitization between morphine analgesia and naloxone-sensitive and cimetidine-sensitive stress-induced analgesia.
    Weinstein IJ; Hough LB; Gogas KR
    J Pharmacol Exp Ther; 1988 Jan; 244(1):253-8. PubMed ID: 3336002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosterone response induced by intracerebroventricular administration of met-enkephalin and naloxone in rats under stress.
    Gadek-Michalska A; Cetera B; Bugajski J
    Folia Med Cracov; 1997; 38(3-4):17-26. PubMed ID: 10481378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent and control of shock affects naltrexone sensitivity of stress-induced analgesia and reactivity to morphine.
    Hyson RL; Ashcraft LJ; Drugan RC; Grau JW; Maier SF
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1019-25. PubMed ID: 6294682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    Comer SD; Burke TF; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid and non-opioid stress analgesia: assessment of tolerance and cross-tolerance with morphine.
    Lewis JW; Sherman JE; Liebeskind JC
    J Neurosci; 1981 Apr; 1(4):358-63. PubMed ID: 7264724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.